
FDA Approves New Bladder Cancer Treatment Before Surgery
The FDA has approved a new bladder cancer treatment combining durvalumab and enfortumab vedotin, reducing recurrence risk by 49%.

AI and treatment gaps worsen CLL care disparities
AI and treatment gaps worsen disparities in CLL care, leaving minority and rural patients less likely to receive guideline-recommended therapies…

Insurance rules limit access to new COPD biologics
Insurance policies now restrict access to new COPD biologics, limiting treatment options for patients with eosinophilic COPD despite medical guidelines.
Oral therapy may expand myeloma treatment access
Oral therapy may expand access to myeloma treatment options for patients worldwide, according to Dr. Mateo Mejia Saldarriaga.

New IL-17 inhibitors outperform others for scalp psoriasis treatment
New research shows IL-17 inhibitors like ixekizumab and brodalumab may offer one of the most effective short-term treatments for scalp…

Tomato Compound Holds Fatty Liver Hope
Tomato compound phytoene shows promise in fighting fatty liver disease, benefiting the estimated 100 million Americans affected. Discover the findings.